Abstract
Objectives: To determine the current practice of smear taking in sexually transmitted infection (STI) clinics within the United Kingdom; what proportion of smears are taken within the national guidelines; whether clinics are screening women not covered by the national screening programme. To compare the abnormality rates of routine and opportunistic (that is, in addition to the screening recommendations) smears; the abnormality rates of smears taken within STI clinics with those taken within the community setting.
Methods: A questionnaire was circulated to all clinics in May 1998. Details of screening practice were requested. The clinics then prospectively collected details of patient's age, GP registration, date and result of previous smear, and current result of all smears taken between 11 May 1998 and 25 May 1998.
Results: There were 1828 smears taken in the 2 week period; 504 (27.6%) were opportunistic. Opportunistic smears had marginal significantly increased rates of low grade abnormalities but lower (but not statistically significant) high grade abnormalities than in routine smears. 231 (12.6%) of the women were not registered with a GP so would not be included in the national programme. The national rates of abnormalities were significantly higher in the STI clinics compared with the community setting.
Conclusion: The majority of smears taken within STI clinics fall within the national guidelines, and 12.6% of the women would probably not otherwise have been screened. The rates of abnormality were significantly higher in the STI clinics but smears taken opportunistically were less likely to have high grade abnormalities. There is no evidence from this study to support the practice of additional smears in the presence of an effective national cytology screening programme.
Key Words: cervical screening; sexually transmitted infection clinics; cytology; United Kingdom
Full Text
The Full Text of this article is available as a PDF (96.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abeyewickreme I. Cervical cytology screening in a sexually transmitted diseases clinic for the first time in Sri Lanka. Genitourin Med. 1989 Apr;65(2):98–102. doi: 10.1136/sti.65.2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Briggs R. M., Holmes K. K., Kiviat N., Barker E., Eschenbach D. A., DeJong R. High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening. Am J Public Health. 1980 Nov;70(11):1212–1214. doi: 10.2105/ajph.70.11.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campbell P. J., Hewitt S. H., Kowalchuk P. A., Joffres M., Romanowski B. Relationships of cervical cytologies to selected variables among women attending a sexually transmitted disease clinic. Int J STD AIDS. 1994 Mar-Apr;5(2):108–112. doi: 10.1177/095646249400500206. [DOI] [PubMed] [Google Scholar]
- Dhar J., Bradley M., Alawettagama A. B. Opportunistic cervical cytology screening in a genitourinary medicine department: is it worthwhile? Genitourin Med. 1993 Dec;69(6):479–480. doi: 10.1136/sti.69.6.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foley E., Harindra V. Cervical cytology: are national guidelines adequate for women attending genitourinary medicine clinics? Sex Transm Infect. 1999 Oct;75(5):349–351. doi: 10.1136/sti.75.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holowaty P., Miller A. B., Rohan T., To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999 Feb 3;91(3):252–258. doi: 10.1093/jnci/91.3.252. [DOI] [PubMed] [Google Scholar]
- Lyttle H., Platts W. M., MacLean A. B. Pilot study of cervical cytology screening in a sexually transmitted diseases clinic. Genitourin Med. 1985 Oct;61(5):330–334. doi: 10.1136/sti.61.5.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quinn M., Babb P., Jones J., Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999 Apr 3;318(7188):904–908. doi: 10.1136/bmj.318.7188.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sasieni P. D., Cuzick J., Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer. 1996 Apr;73(8):1001–1005. doi: 10.1038/bjc.1996.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sasieni P., Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ. 1999 May 8;318(7193):1244–1245. doi: 10.1136/bmj.318.7193.1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwebke J. R., Zajackowski M. E. Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med. 1997 Oct;73(5):383–386. doi: 10.1136/sti.73.5.383. [DOI] [PMC free article] [PubMed] [Google Scholar]